Regulatory
Sprint Through Real-Time Promo Review
Agility benefits the entire value chain process, from basic research to clinical development, to ...
Words & Functionalities Matter: FDA Regulation of Consumer Software and Apps
Today, understanding whether digital health software or apps are actively regulated as medical devices ...
From Capitol Hill to the Oval Office: What Washington Has in Store for Pharma and Healthcare Communications in 2019
With 71% of voters citing it as their foremost concern, healthcare was among the ...
Progress Toward an Ethical Mindset
Everyone agrees that industry must move from rules- to values-based decision-making to ensure compliance ...
Talking About Your Pipeline
Ahead of commercialization, companies developing drugs and medical devices communicate about their pipeline products ...
Optimize Content Quality Globally
With anticipated launches of novel therapies and increasing sales for currently marketed prescription products, ...
Patient Experience Data and R&D
As the U.S. Food and Drug Administration (FDA) works to issue more guidance for ...
Technology Optimized Content
With the sheer volume and complexity of promotional materials today, it’s not surprising that ...
PFDD: A Game Changer?
The 21st Century Cures Act (Cures Act), which was passed by Congress, includes mandates ...
Pitfalls of Generic Drug Marketing
While many advertising agencies, companies, healthcare professionals, and consumers alike may not realize it, ...
That “Can Do” Attitude
Companies that are committed to patient-centered healthcare must incorporate the patient’s voice in all ...
Exhibit Displays: Beware the FDA
Companies attending large medical meetings to showcase innovative and marketed drug products alike should ...
The Trouble with Sampling in the State of Ohio
Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...
